Research Update: Spironolactone saves lives in heart failure
Year: 1999
Type: article
Abstract: The aldosterone antagonist spironolactone cuts the risk of death and the rate of hospitalization by one-third in patients with severe heart failure, according to a large international study. The multicentre study was stopped earlier than planned and its results have been released on the Internet (
Source: Europe PMC (PubMed Central)
Author: Carl J. Brown
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W1750789367